Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge

Summary: Background: Ebola virus (EBOV), variant Makona, was the causative agent of the 2013–2016 West African epidemic responsible for almost 30,000 human infections and over 11,000 fatalities. During the epidemic, the development of several experimental vaccines was accelerated through human clin...

Full description

Bibliographic Details
Main Authors: Andrea Marzi, Pierce Reynolds, Reinaldo Mercado-Hernandez, Julie Callison, Friederike Feldmann, Rebecca Rosenke, Tina Thomas, Dana P. Scott, Patrick W. Hanley, Elaine Haddock, Heinz Feldmann
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419306516